Market Size and Overview ctNA (Circulating Tumor Nucliec Acids) segment in the global liquid biopsy market was valued at US$ 250.0 Mn in 2019 and is expected to reach US$ 1,723.6 Mn by 2027 at a CAGR of 27.3% during the forecast period. https://hallbook.com.br/blogs/739395/Liquid-Biopsy-Market-Size-and-Growth-Driven-by-Advanced-Diagnostics